Howe Orla, O'Malley Kiaran, Lavin Martin, Gardner Robert A, Seymour Colin, Lyng Fiona, Mulvin David, Quinlan David M, Mothersill Carmel
Radiation and Environmental Science Centre, Focus Institute, Dublin Institute of Technology, Dublin 8, Ireland.
Radiat Res. 2005 Nov;164(5):627-34. doi: 10.1667/rr3454.1.
Cells respond to genotoxic insults such as ionizing radiation by halting in the G2 phase of the cell cycle. Delayed cell death (mitotic death) can occur when the cell is released from G2, and specific spindle defects form endopolyploid cells (endoreduplication/tetraploidy). Enhanced G2 chromosomal radiosensitivity has been observed in many cancers and genomic instability syndromes, and it is manifested by radiation-induced chromatid aberrations observed in lymphocytes of patients. Here we compare the G2 chromosomal radiosensitivity in prostate patients with benign prostatic hyperplasia (BPH) or prostate cancer with disease-free controls. We also investigated whether there is a correlation between G2 chromosomal radiosensitivity and aneuploidy (tetraploidy and endoreduplication), which are indicative of mitotic cell death. The G2 assay was carried out on all human blood samples. Metaphase analysis was conducted on the harvested chromosomes by counting the number of aberrations and the mitotic errors (endoreduplication/tetraploidy) separately per 100 metaphases. A total of 1/14 of the controls were radiosensitive in G2 compared to 6/15 of the BPH patients and 15/17 of the prostate cancer patients. Radiation-induced mitotic inhibition was assessed to determine the efficacy of G2 checkpoint control in the prostate patients. There was no significant correlation of G2 radiosensitivity scores and mitotic inhibition in BPH patients (P = 0.057), in contrast to prostate cancer patients, who showed a small but significant positive correlation (P = 0.029). Furthermore, there was no significant correlation between G2 radiosensitivity scores of BPH patients and endoreduplication/ tetraploidy (P = 0.136), which contrasted with an extremely significant correlation observed in prostate cancer patients (P < 0.0001). In conclusion, cells from prostate cancer patients show increased sensitivity to the induction of G2 aberrations from ionizing radiation exposure but paradoxically show reduced mitotic indices and aneuploidy as a function of aberration frequency.
细胞通过在细胞周期的G2期停滞来应对诸如电离辐射等基因毒性损伤。当细胞从G2期释放时,可能会发生延迟性细胞死亡(有丝分裂死亡),并且特定的纺锤体缺陷会形成内多倍体细胞(核内复制/四倍体)。在许多癌症和基因组不稳定综合征中都观察到了增强的G2染色体放射敏感性,其表现为在患者淋巴细胞中观察到的辐射诱导的染色单体畸变。在这里,我们比较了患有良性前列腺增生(BPH)或前列腺癌的前列腺患者与无病对照者的G2染色体放射敏感性。我们还研究了G2染色体放射敏感性与非整倍体(四倍体和核内复制)之间是否存在相关性,非整倍体是有丝分裂细胞死亡的指标。对所有人类血液样本进行G2检测。通过分别计算每100个中期相中畸变的数量和有丝分裂错误(核内复制/四倍体)的数量,对收获的染色体进行中期分析。与1/14的对照者在G2期对辐射敏感相比,BPH患者中有6/15,前列腺癌患者中有15/17对辐射敏感。评估辐射诱导的有丝分裂抑制作用,以确定G2检查点控制在前列腺患者中的功效。BPH患者的G2放射敏感性评分与有丝分裂抑制之间无显著相关性(P = 0.057),而前列腺癌患者则显示出小但显著的正相关性(P = 0.029)。此外,BPH患者的G2放射敏感性评分与核内复制/四倍体之间无显著相关性(P = 0.136),这与在前列腺癌患者中观察到的极其显著的相关性形成对比(P < 0.0001)。总之,前列腺癌患者的细胞对电离辐射暴露诱导的G2畸变表现出更高的敏感性,但矛盾的是,作为畸变频率的函数,其有丝分裂指数和非整倍体减少。